Customer Center
Login | Register

The Faces of Luminex: Jennifer Hackel, Talent Acquisition & Organizational Development

September 22nd, 2017 / Christine Valle

The Luminex family wouldn’t look the same without the efforts of one woman: Jennifer Hackel, Manager of Talent Acquisition and Organizational Development. At any given time, she’s handling recruitment for as many as 30 open positions within the company. Hackel, who joined Luminex in 2013, earned her bachelor’s degree in communication from Marquette University and

Continue reading »

Choosing an MDx Platform

September 21st, 2017 / Scott Henderson

Important factors to consider for meeting a community’s infectious disease needs Recently, clinical laboratories have seen a dramatic increase in the adoption of molecular diagnostic systems for infectious disease testing. These platforms support a laboratory’s need to generate clinically actionable data faster than ever before, compared to traditional methods, without compromising reliable performance. However, with

Continue reading »

Protagen is Taking Biomarkers from the Bench to the Bedside

September 19th, 2017 / Hilary Graham

The FLEXMAP 3D® supports high-throughput discovery of autoantibody biomarker candidates Peter Schulz-Knappe is the Chief Scientific Officer at Protagen AG, based in Germany. Protagen is using Luminex’s FLEXMAP 3D® as part of its SeroTag® biomarker identification and development platform to create assays to support the development of drugs and companion diagnostics. When developing your protein

Continue reading »

Meet Multiplexing Experts at xMAP® Connect Boston

September 11th, 2017 / Hilary Graham

Learn about the diverse applications of xMAP® Technology and spark inspiration for your next experiment Most conferences focus on research advances and the development of therapies for specific diseases. xMAP® Connect is different. Whether you’re a multiplexing expert eager to share your work or just getting started – xMAP Connect is the premier event for

Continue reading »

The Faces of Luminex: Terry Knighton, Instrument Manufacturing

September 8th, 2017 / Christine Valle

The teams responsible for engineering and building Luminex instruments adhere to the strictest quality controls — one of the leaders of this team is Terry Knighton, Director of Instrument Manufacturing. Trained as an electrical engineer with a bachelor’s degree from Prairie View A&M University and a master’s from Iowa State University, he joined Luminex in

Continue reading »

It’s Time to Talk About Blood Poisoning

September 7th, 2017 / Christine Valle

This September, help raise sepsis awareness Did you know that someone in the U.S. dies from sepsis every two minutes? Sepsis is the leading cause of death in U.S. hospitals — there are more deaths from sepsis than from prostate cancer, breast cancer, and AIDS combined. That’s why it’s so important that September is Sepsis

Continue reading »

Luminex Licensed Technologies Partner Spotlight: CD Diagnostics

September 5th, 2017 / Hilary Graham

Developing Periprosthetic Joint Infection diagnostic assays Luminex Licensed Technologies Partners represent a diversity of market segments, company sizes, and geographies. The versatility of xMAP® Technology has supported the launch of thousands of analytes formatted into commercially available kits and testing services. Alexander Cameron, Diagnostics Global Product Manager at Zimmer Biomet, shares his journey with Luminex

Continue reading »

The Faces of Luminex: Hilary Graham, Scientific Marketing

August 25th, 2017 / Christine Valle

What do you do when you enjoy communicating about science as much as the science itself? After earning her bachelor’s degree in biochemistry and molecular biology at the University of California, Davis, and her master’s in cell and molecular biology at the University of Texas at Austin, Hilary Graham, Senior Manager of Scientific Marketing, shifted gears

Continue reading »

Galapagos is Putting an End to Inflammatory Disease

August 22nd, 2017 / Hilary Graham

Automated assay workflow supports high-throughput target validation Jan Stallen and Anais Legent are target discovery scientists at Galapagos, based in The Netherlands. Galapagos was founded in 1999 and has since built a pipeline that currently consists of 16 clinical, two pre-clinical, and 20 discovery programs that are advancing small molecule drug candidates against inflammatory diseases

Continue reading »

From the Trenches: Expert Guidance for Molecular GI Testing

August 17th, 2017 / Christine Valle

Clinical and lab professionals share best practices, assay evaluations If gastrointestinal pathogen testing is part of your job, don’t miss this informative webinar from two experts in the field. “Fecal Matters: Clinician and Laboratorian Perspective on Impact of Molecular GI Pathogen Testing” features speakers from clinical labs in Utah and North Carolina who offer case studies

Continue reading »